ReviewReviews in endocrine & metabolic disorders2026
Modulation of hepcidin synthesis: the core link in the bi-directional relationship between iron and obesity.
Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gut microbiota and iron deficiency anemia: Mechanisms, microbial signatures, and dietary interactions (A narrative review).Asia Pacific journal of clinical nutrition · 2026Review
- Review
- Borderline liver enzyme patterns and their metabolic-inflammatory signatures: an observational outpatient study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Over the past five decades, clinical and experimental data have established that iron metabolism, lipid metabolism, and obesity are intricately linked and differentially influence one another through complex metabolic pathways. Iron dyshomeostasis is now recognized as a key modulator of lipid metabolism, with profound implications for obesity and related metabolic disorders. Likewise, lipid metabolism and obesity significantly impact iron absorption and recycling. Although this interplay between iron metabolism, lipid metabolism, and obesity is complex, modulation of hepcidin synthesis seems to be the core link between these variables. As the global prevalence of metabolic disorders continues to escalate, understanding their multifactorial etiology has become a public health priority. Emerging evidence highlights the dysregulation of lipid metabolism as a central driver in the onset and progression of these conditions, with iron metabolism playing a crucial regulatory role. This review explores the relationship between iron metabolism on one hand and lipid metabolism and obesity on the other with specific emphasis on the molecular mechanisms underlying this relationship. The review also explores the bi-directional relationship between iron metabolism and mitochondrial functions, mainly energy production. It concludes by outlining the pathophysiological consequences of disrupted iron metabolism, vis-a-vis lipid metabolism, obesity, and diabetes. By synthesizing current knowledge, this review aims to provide new insights that could guide the development of novel therapeutic strategies to manage obesity, diabetes, and related metabolic disorders.
Indexed as
Identifiers
41055645What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.